| Laurus Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540222 |
NSE Symbol : LAURUSLABS |
P/E(TTM) : 101.32 |
|
ISIN Demat : INE947Q01028 |
Div & Yield% : 0.14 |
EPS(TTM) : 13.76 |
|
Book Value(₹) : 97.21 |
Market Cap(₹Cr) : 75,316.19 |
Face Value(₹) : 2.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 6,089.07 | 5,216.98 | 4,812.39 | 5,773.45 | 4,707.04 |
| Other Income | 77.43 | 100.47 | 47.42 | 15.95 | 21.55 |
| Stock Adjustments | 236.87 | 13.55 | 102.48 | -40.82 | 218.62 |
| Total Income | 6,403.37 | 5,331.00 | 4,962.29 | 5,748.58 | 4,947.21 |
| EXPENDITURE : | |||||
| Raw Materials | 2,797.49 | 2,476.74 | 2,507.87 | 2,671.65 | 2,427.18 |
| Power and Fuel Cost | 330.61 | 289.49 | 309.67 | 301.10 | 188.52 |
| Other Manufacturing Expenses | 585.95 | 482.35 | 491.94 | 431.99 | 326.34 |
| Selling and Administration Expenses | 393.76 | 393.12 | 293.96 | 323.95 | 265.52 |
| Miscellaneous Expenses | 96.35 | 73.72 | 29.62 | 44.30 | 15.33 |
| Employee Benefit Expenses | 683.52 | 570.78 | 531.93 | 477.88 | 417.57 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,515.69 | 1,044.80 | 797.30 | 1,497.71 | 1,306.75 |
| Interest | 142.96 | 182.20 | 150.82 | 145.70 | 95.86 |
| Gross Profit | 1,372.73 | 862.60 | 646.48 | 1,352.01 | 1,210.89 |
| Depreciation | 378.64 | 358.79 | 345.01 | 300.58 | 235.48 |
| Profit Before Tax | 994.09 | 503.81 | 301.47 | 1,051.43 | 975.41 |
| Current Tax | 285.12 | 153.84 | 87.94 | 270.78 | 231.42 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -31.51 | -30.42 | -10.17 | 20.27 | -6.10 |
| Reported Net Profit | 740.48 | 380.39 | 223.70 | 760.38 | 750.09 |
| Extraordinary Items | -3.17 | 75.87 | -0.57 | -0.14 | -0.85 |
| Adjusted Net Profit | 743.65 | 304.52 | 224.27 | 760.52 | 750.94 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 3,704.87 | 3,367.61 | 3,230.09 | 2,577.18 | 1,912.95 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 86.33 | 43.13 | 86.18 | 107.47 | 85.86 |
| P & L Balance carried down | 4,359.02 | 3,704.87 | 3,367.61 | 3,230.09 | 2,577.18 |
| Dividend | 86.33 | 43.13 | 86.18 | 107.47 | 85.86 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 100.00 | 60.00 | 40.00 | 100.00 | 100.00 |
| Dividend Per Share(Rs) | 2.00 | 1.20 | 0.80 | 2.00 | 2.00 |
| Earnings Per Share-Unit Curr | 13.72 | 7.05 | 4.15 | 14.12 | 13.96 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 97.29 | 84.64 | 78.06 | 75.31 | 63.05 |
| Book Value(Adj)-Unit Curr | 97.29 | 84.64 | 78.06 | 75.31 | 63.05 |
